Alnylam Pharmaceuticals
ALNY
#541
Rank
S$57.00 B
Marketcap
S$431.51
Share price
0.26%
Change (1 day)
14.87%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company